Purchase Order HHSN261201600019A
Award Date 9/11/16
Potential Completion Date 9/10/21
Potential Value $143K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $263,862.50 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the procurement of laboratory equipment and supplies, specifically various Illumina sequencing systems, reagents, and consumables to support the NCI Surgery Branch's genetic sequencing needs. The award does not have a set-aside designation. Illumina has previously received other prime federal...
- This is a $17,508.94 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is not set aside for any special designation. Illumina has previously been awarded prime federal contracts and subcontracts by agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems, consumables, and...
- This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomics sequencing and analysis solutions. The contract, valued at $15,388.08, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics. Illumina has a history of providing similar products and services to various federal agencies, including the NIH, CDC, USDA, and VA, under...
- This is a $28,749.60 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of laboratory equipment and supplies, with no set-aside designation. Through this award, Illumina will provide the NCI with a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample prep kits,...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $24,797.20 firm-fixed-price delivery order is for Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. No set-aside was used. Illumina has a history of providing these types of products and services to...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $24,230.96 contract provides Illumina sequencing systems, reagents, and services to support genomic research and diagnostics. The award is not associated with a set-aside program. Through past prime contract and subcontract awards, Illumina has...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $90,461.80 order is for reagents and consumables to support the agency's genomic sequencing and analysis needs. Illumina has previously received other prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems and related...
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency of the Department of Health and Human Services, to Illumina, Inc. for $79,576.32. The contract is for the delivery of biological kits, Illumina sequencing systems, and related services. It is a firm fixed-price delivery order with no set-aside designation. Illumina is a manufacturer of genomic sequencing and analysis instruments and reagents, and has previously been awarded prime contracts and...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $88,491.16, is for the delivery of biological kits and Illumina sequencing equipment and consumables. The contract has no set-aside designation. Illumina has previously held prime contracts and subcontracts with various...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract, valued at $209,924.10, is for the provision of reagents and consumables to support genomic sequencing and analysis. Illumina has previously received prime and subcontract awards from various federal agencies, including the NIH, CDC, USDA, and VA, to provide a range of sequencing...